PHILADELPHIA (MedPage Today) -- Six-month data on an investigational oral anti-inflammatory drug confirmed its effectiveness as second-line therapy for rheumatoid arthritis, but it was a bust in patients who had failed biologic therapy, researchers said here.

The University of Alabama at Birmingham (UAB) is spearheading an effort to create a national database and repository to enable researchers to identify predictors of effectiveness of various treatments for rheumatoid arthritis (RA). RA is the most common type of inflammatory arthritis. Many effective medications exist, but they vary greatly in cost and side effects, and there is no way to predict which drug will work best on an individual. A two-year, $3.3 million Grand Opportunity (GO) grant f

PHILADELPHIA (MedPage Today) -- Women who frequently sprayed their homes with insecticides over a period of years may have put themselves at risk for autoimmune diseases such as rheumatoid arthritis and lupus, a researcher said here.

PHILADELPHIA (MedPage Today) -- Patients with rheumatoid arthritis appear to fare equally whether they start treatment with traditional, disease-modifying anti-rheumatic drugs or newer biologic agents that target the basic disease process, researchers said here.

U.S. women living with rheumatoid arthritis demand more ‘good days’ 68 percent of women living with rheumatoid arthritis look for new pain relief therapies to help them cope Almost 60 percent of women in the U.S. living with rheumatoid arthritis find intimate relations painful Rheumatoid arthritis played a role in 25 percent of divorces amongst women with the disease A new survey of U.S. women living with rheumatoid arthritis (RA) published today reveals that RA has a clear emoti